1
|
Zhu H, Dronamraju V, Xie W, More SS. Sulfur-containing therapeutics in the treatment of Alzheimer's disease. Med Chem Res 2021; 30:305-352. [PMID: 33613018 PMCID: PMC7889054 DOI: 10.1007/s00044-020-02687-1] [Citation(s) in RCA: 14] [Impact Index Per Article: 4.7] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/31/2020] [Accepted: 12/06/2020] [Indexed: 12/12/2022]
Abstract
Sulfur is widely existent in natural products and synthetic organic compounds as organosulfur, which are often associated with a multitude of biological activities. OBenzothiazole, in which benzene ring is fused to the 4,5-positions of the thiazolerganosulfur compounds continue to garner increasing amounts of attention in the field of medicinal chemistry, especially in the development of therapeutic agents for Alzheimer's disease (AD). AD is a fatal neurodegenerative disease and the primary cause of age-related dementia posing severe societal and economic burdens. Unfortunately, there is no cure for AD. A lot of research has been conducted on sulfur-containing compounds in the context of AD due to their innate antioxidant potential and some are currently being evaluated in clinical trials. In this review, we have described emerging trends in the field, particularly the concept of multi-targeting and formulation of disease-modifying strategies. SAR, pharmacological targets, in vitro/vivo ADMET, efficacy in AD animal models, and applications in clinical trials of such sulfur compounds have also been discussed. This article provides a comprehensive review of organosulfur-based AD therapeutic agents and provides insights into their future development.
Collapse
Affiliation(s)
- Haizhou Zhu
- Center for Drug Design, College of Pharmacy, University of Minnesota, Minneapolis, MN 55455, USA
| | - Venkateshwara Dronamraju
- Center for Drug Design, College of Pharmacy, University of Minnesota, Minneapolis, MN 55455, USA
| | - Wei Xie
- Center for Drug Design, College of Pharmacy, University of Minnesota, Minneapolis, MN 55455, USA
| | - Swati S. More
- Center for Drug Design, College of Pharmacy, University of Minnesota, Minneapolis, MN 55455, USA
| |
Collapse
|
2
|
Ivachtchenko AV. Sulfonyl-containing modulators of serotonin 5-HT6receptors and their pharmacophore models. RUSSIAN CHEMICAL REVIEWS 2014. [DOI: 10.1070/rc2014v083n05abeh004371] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
|
3
|
Nirogi RV, Kambhampati R, Kothmirkar P, Konda J, Bandyala TR, Gudla P, Arepalli S, Gangadasari NP, Shinde AK, Deshpande AD, Dwarampudi A, Chindhe AK, Dubey PK. Synthesis and structure–activity relationship of novel conformationally restricted analogues of serotonin as 5-HT6 receptor ligands. J Enzyme Inhib Med Chem 2011; 27:443-50. [DOI: 10.3109/14756366.2011.595713] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Affiliation(s)
- Ramakrishna V.S. Nirogi
- Discovery Research-Medicinal Chemistry, Suven Life Sciences Ltd.,
Banjara Hills, Hyderabad, India
| | - Ramasastri Kambhampati
- Discovery Research-Medicinal Chemistry, Suven Life Sciences Ltd.,
Banjara Hills, Hyderabad, India
| | - Prabhakar Kothmirkar
- Discovery Research-Medicinal Chemistry, Suven Life Sciences Ltd.,
Banjara Hills, Hyderabad, India
| | - Jagadishbabu Konda
- Discovery Research-Medicinal Chemistry, Suven Life Sciences Ltd.,
Banjara Hills, Hyderabad, India
| | - Thrinath Reddy Bandyala
- Discovery Research-Medicinal Chemistry, Suven Life Sciences Ltd.,
Banjara Hills, Hyderabad, India
| | - Parandhama Gudla
- Discovery Research-Medicinal Chemistry, Suven Life Sciences Ltd.,
Banjara Hills, Hyderabad, India
| | - Sobhanadri Arepalli
- Discovery Research-Medicinal Chemistry, Suven Life Sciences Ltd.,
Banjara Hills, Hyderabad, India
| | | | - Anil K. Shinde
- Discovery Research-Medicinal Chemistry, Suven Life Sciences Ltd.,
Banjara Hills, Hyderabad, India
| | - Amol D. Deshpande
- Discovery Research-Medicinal Chemistry, Suven Life Sciences Ltd.,
Banjara Hills, Hyderabad, India
| | - Adireddy Dwarampudi
- Discovery Research-Medicinal Chemistry, Suven Life Sciences Ltd.,
Banjara Hills, Hyderabad, India
| | - Anil K. Chindhe
- Discovery Research-Medicinal Chemistry, Suven Life Sciences Ltd.,
Banjara Hills, Hyderabad, India
| | - Pramod Kumar Dubey
- Department of Chemistry, Jawaharlal Nehru Technological University Hyderabad,
Kukatpally, Hyderabad, India
| |
Collapse
|